Physician profile
Robert J Stabile
NPI 1023205341
$14,258.16
in general payments reported to CMS, 2019-2025
35 companies · $2,720 in 2025
The $2,720 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $2,437 · 2021: $2,362 · 2022: $1,286 · 2023: $1,968 · 2024: $2,897 · 2025: $2,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,571 · Travel and Lodging: $14.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,571.25 |
| Travel and Lodging | $14.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,864.48 | 2019-2025 | Oasis, Collagenase Santyl, Grafix Pl |
| Osteomed LLC | $1,868.43 | 2019-2022 | |
| Stryker Corporation | $1,220.16 | 2022-2025 | Citrefix, Flexband, Augment Injectable |
| Gotham Surgical Solutions & Devices, INC. | $1,213.43 | 2021-2022 | |
| Bioventus LLC | $932.61 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Sonicone Clinic |
| Abbvie INC. | $727.37 | 2021-2025 | Dalvance, Teflaro, Avycaz |
| Treace Medical Concepts, INC. | $623.04 | 2024-2025 | |
| Polynovo North America LLC | $550.52 | 2020-2025 | Novosorb Btm |
| Misonix INC | $449.18 | 2019-2021 | |
| Integra Lifesciences Corporation | $353.45 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medela LLC | $289.50 | 2020-2021 | |
| Allergan, INC. | $277.48 | 2019-2020 | |
| Biocomposites INC | $260.06 | 2021-2024 | |
| Acumed LLC | $249.28 | 2023-2024 | Osteomed, Acumed, Montage 5cc |
| Avita Medical Americas, LLC | $230.88 | 2024-2025 | Cohealyx, Permeaderm, Recell |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $211.32 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac, Prevena |
| Tactile Systems Technology INC | $200.63 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Organogenesis INC. | $191.60 | 2023-2025 | Puraply Antimicrobial, Apligraf, Puraply |
| Paragon 28, INC. | $191.55 | 2023-2025 | Additive Orthopedics, Monkey Rings |
| Kci USA, INC. | $186.08 | 2019-2023 | Prevena Restor Arthroform, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Kerecis Limited | $160.79 | 2020-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $149.26 | 2020-2025 | Gii, Gryphon Orthocord, Speedtrap |
| Next Science LLC | $134.44 | 2024-2025 | Xperience, Blastx, Surgx |
| Cumberland Pharmaceuticals, INC. | $134.30 | 2022-2024 | Caldolor, Vibativ |
| Averitas Pharma INC. | $110.86 | 2023-2025 | Qutenza |
| Lifenet Health | $110.65 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $67.16 | 2023-2024 | |
| Orthofix Medical, INC. | $59.64 | 2019-2025 | Physio-Stim |
| Medtronic, INC. | $56.39 | 2023 | Intellis Adaptivestim |
| Convatec INC. | $44.26 | 2019-2024 | |
| Access Pro Medical, LLC | $41.33 | 2025 | Matriderm |
| Paratek Pharmaceuticals, INC. | $39.23 | 2020-2021 | |
| Imbed Biosciences INC. | $25.08 | 2022 | |
| Hydrofera LLC | $18.01 | 2021 | |
| Arteriocyte Medical Systems, INC. | $15.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Stabile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.